- TheStreet.com•1 hour ago
Current drugs approved to prevent and reduce the frequency of HAE swelling attacks require injections, so BioCryst's once-daily pill has the potential to be more convenient.
- TheStreet.com•2 hours ago
BioCryst Pharmaceuticals, Sangamo Therapeutics and Cempra were among the biotech stock movers in premarket trading on Monday.
- TheStreet.com•3 hours ago
Shares of BioCryst (BCRX) fell double digits despite topping analysts' 4Q expectations.
BCRX : Summary for BioCryst Pharmaceuticals, Inc. - Yahoo Finance
BioCryst Pharmaceuticals, Inc. (BCRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||5.20 x 300|
|Ask||5.21 x 3900|
|Day's Range||4.20 - 5.35|
|52 Week Range||1.89 - 7.56|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-5.71|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|